1,555
Views
24
CrossRef citations to date
0
Altmetric
Research Article

The chemical constituents of Piper kadsura and their cytotoxic and anti-neuroinflammtaory activities

, , , , , & show all
Pages 254-260 | Received 11 Feb 2010, Accepted 20 May 2010, Published online: 05 Aug 2010
 

Abstract

The n-hexane and CHCl3 soluble fractions of the MeOH extract of the aerial parts of Piper kadsura were found to potently inhibit nitric oxide (NO) production in LPS-activated BV-2 cells, a microglial cell line. From the active fractions, a new stereoisomer of guaiane sesquiterpene, 1α,5β-guai-4(15)-ene-6β,10β-diol, kadsuguain A (1) and a new cyclohexadienone, kadsuketanone A (2), together with twelve known compounds (314) were isolated. The structures of these compounds were elucidated by extensive NMR spectral studies. The absolute configuration of 2 was determined by circular dichroism (CD) spectra. Compounds 2, 6, and 1114 significantly inhibited both nitric oxide (NO) and prostaglandin E2 (PGE2) production in the LPS-activated microglia cells. In addition, compounds 4, 6, and 1114 exhibited cytotoxicity against the A549, SK-OV-3, SK-MEL-2, and HCT15 human tumour cells.

Acknowledgements

The authors would like to thank Do Kyun Kim, Eun Jung Bang, and Jung Ju Seo at the Korea Basic Science Institute for the NMR and MS spectral measurements.

Declaration of interest

This study was supported by a grant from the Seoul R&BD Program (10524) funded by the Seoul Metropolitan Government, Republic of Korea.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.